PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study
Autor: | Ferrarotto, Renata, Swiecicki, Paul L., Zandberg, Dan P., Baiocchi, Robert A., Wesolowski, Robert, Rodriguez, Cristina P., McKean, Meredith, Kang, Hyunseok, Monga, Varun, Nath, Rajneesh, Palmisiano, Neil, Babbar, Naveen, Sun, William, Hanna, Glenn J. |
---|---|
Zdroj: | In Oral Oncology February 2024 149 |
Databáze: | ScienceDirect |
Externí odkaz: |